Pliant Therapeutics (PLRX) Retained Earnings (2019 - 2025)
Historic Retained Earnings for Pliant Therapeutics (PLRX) over the last 7 years, with Q3 2025 value amounting to -$835.8 million.
- Pliant Therapeutics' Retained Earnings fell 2657.79% to -$835.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$835.8 million, marking a year-over-year decrease of 2657.79%. This contributed to the annual value of -$710.1 million for FY2024, which is 4208.2% down from last year.
- Pliant Therapeutics' Retained Earnings amounted to -$835.8 million in Q3 2025, which was down 2657.79% from -$809.5 million recorded in Q2 2025.
- Pliant Therapeutics' 5-year Retained Earnings high stood at -$140.7 million for Q1 2021, and its period low was -$835.8 million during Q3 2025.
- Over the past 5 years, Pliant Therapeutics' median Retained Earnings value was -$417.2 million (recorded in 2023), while the average stood at -$450.0 million.
- In the last 5 years, Pliant Therapeutics' Retained Earnings crashed by 9876.14% in 2021 and then plummeted by 2657.79% in 2025.
- Pliant Therapeutics' Retained Earnings (Quarter) stood at -$215.1 million in 2021, then tumbled by 57.33% to -$338.4 million in 2022, then crashed by 47.67% to -$499.7 million in 2023, then crashed by 42.08% to -$710.1 million in 2024, then fell by 17.71% to -$835.8 million in 2025.
- Its last three reported values are -$835.8 million in Q3 2025, -$809.5 million for Q2 2025, and -$766.2 million during Q1 2025.